STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] DANAHER CORP /DE/ Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Danaher (DHR) reported an insider transaction by its EVP & Chief Financial Officer, Matthew McGrew. On 11/11/2025, he exercised 16,172 employee stock options at an exercise price of $62.85 per share and sold 16,172 common shares at a weighted average price of $214.6198.

Following these transactions, McGrew beneficially owns 20,062 common shares directly and 10,221.856 shares indirectly via a 401(k). The sale price reflected multiple trades between $214.580 and $214.810.

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McGrew Matthew

(Last) (First) (Middle)
2200 PENNSYLVANIA AVENUE, NW
SUITE 800W

(Street)
WASHINGTON DC 20037

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DANAHER CORP /DE/ [ DHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/11/2025 M 16,172 A $62.85 36,234 D
Common Stock 11/11/2025 S 16,172 D $214.6198(1) 20,062 D
Common Stock 10,221.856 I By 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee stock option (right to buy) $62.85 11/11/2025 M 16,172 (2) 11/15/2025 Common Stock 16,172 $0 0 D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.580 to $214.810, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
2. One third of the options granted became exercisable on each of the third, fourth and fifth anniversaries of the grant date, which was November 15, 2015.
Remarks:
/s/ James F. O'Reilly, attorney-in-fact for Matthew McGrew 11/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Danaher (DHR) disclose in this Form 4?

The CFO, Matthew McGrew, exercised 16,172 stock options at $62.85 and sold 16,172 shares at a weighted average of $214.6198 on 11/11/2025.

How many Danaher shares does the CFO own after the transaction?

He holds 20,062 shares directly and 10,221.856 shares indirectly through a 401(k).

What was the price range for the Danaher share sales?

Sales occurred at prices ranging from $214.580 to $214.810, with a weighted average of $214.6198.

What was the exercise price of the options used by the Danaher CFO?

The employee stock options had an exercise price of $62.85 per share.

How many options remain after the reported transactions?

The report shows 0 derivative securities remaining after exercising 16,172 options tied to this grant.

What is the role of the reporting person at Danaher (DHR)?

Matthew McGrew is Danaher’s EVP & Chief Financial Officer.
Danaher Corporation

NYSE:DHR

DHR Rankings

DHR Latest News

DHR Latest SEC Filings

DHR Stock Data

156.25B
629.05M
11.05%
82.81%
1.33%
Diagnostics & Research
Industrial Instruments for Measurement, Display, and Control
Link
United States
WASHINGTON